Skip to content
Home
About Us
Company Overview
Management Team
Board of Directors
Scientific Advisory Board
Our Focus
LVAD
ESKD + AFib
APS
Research & Development
Tecarfarin
Pipeline
Clinical Trials
Investors
Overview
Press Releases
Stock Information
Analyst Coverage
SEC Filings
Governance
Email Alerts
Contact
Menu
Home
About Us
Company Overview
Management Team
Board of Directors
Scientific Advisory Board
Our Focus
LVAD
ESKD + AFib
APS
Research & Development
Tecarfarin
Pipeline
Clinical Trials
Investors
Overview
Press Releases
Stock Information
Analyst Coverage
SEC Filings
Governance
Email Alerts
Contact
SEC Filings
Advancing the development of tecarfarin for unmet needs in anticoagulation therapy
sec filings
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
